# Effects of Intensive cART During Acute/Early HIV Infection

> **NCT01154673** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Toronto** · enrollment: 32 (actual)

## Conditions studied

- Acute HIV Infection

## Interventions

- **DRUG:** raltegravir
- **DRUG:** maraviroc
- **DRUG:** emtricitabine 200mg /tenofovir 300mg
- **DRUG:** lopinavir 400 mg/ritonavir 100mg

## Key facts

- **NCT ID:** NCT01154673
- **Lead sponsor:** University of Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2016-04-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01154673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01154673, "Effects of Intensive cART During Acute/Early HIV Infection". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01154673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*